
Ravu100 mg
Square Pharmaceuticals PLC.
Ravuconazole is a triazole antifungal agent that has been evaluated in clinical development for the treatment of fungal infections.
Ravuconazole is a triazole antifungal agent that has been evaluated in clinical development for the treatment of fungal infections. Its use should be classified by the strength of available evidence:
Ravuconazole has not received marketing approval from the US FDA, and its availability as a standalone marketed product should be confirmed with a physician or pharmacist before use. A closely related prodrug of Ravuconazole has gained regulatory approval in some countries specifically for onychomycosis. Ravuconazole should only be used under the direct supervision of a qualified physician, who will confirm whether it is an appropriate and available option for a given infection.
There is no single, universally standardized approved dosing regimen for Ravuconazole in every market; the dose, frequency, and duration of Ravuconazole therapy must always be individualized and confirmed by the prescribing physician based on the specific infection being treated, the patient's organ function, and local product labeling.
| Indication | Adult dosing pattern studied | Typical duration |
|---|---|---|
| Esophageal/oropharyngeal candidiasis | Oral once-daily dosing, generally in the range of 100 mg to 200 mg per day, often with a higher loading dose on day one | Approximately 2–3 weeks, guided by clinical response |
| Invasive candidiasis / invasive aspergillosis | Higher once-daily oral doses (individualized), sometimes with an initial loading regimen | Individualized; typically several weeks under specialist supervision |
| Onychomycosis (nail fungal infection) | Extended intermittent (e.g., once-weekly) oral regimens have been studied, taking advantage of the long half-life of this drug class | Typically 12 weeks or longer, per treating physician |
Antimicrobial stewardship: Take Ravuconazole exactly as prescribed by your physician. Do not stop, extend, skip doses, change the dose, or share Ravuconazole with another person without medical advice, even if symptoms improve before the prescribed course is finished, as incomplete treatment can lead to relapse or drug-resistant fungal infection.
Most people tolerate Ravuconazole well, but as with other azole antifungals, side effects can occur.
Patients should seek prompt medical attention for yellowing of the skin/eyes, severe abdominal pain, unusual tiredness, irregular heartbeat, fainting, or signs of a severe allergic reaction while taking Ravuconazole.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.